Log in
LON:BIOG

The Biotech Growth Trust PLC (BIOG.L) Share Forecast, Price & News

GBX 1,388.75
-5.25 (-0.38 %)
(As of 10/23/2020 03:48 PM ET)
Add
Today's Range
1,379.56
Now: GBX 1,388.75
1,404
50-Day Range
1,170
MA: GBX 1,356.78
1,484
52-Week Range
680
Now: GBX 1,388.75
1,518
Volume101,921 shs
Average Volume108,768 shs
Market Capitalization£544.49 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
The Biotech Growth Trust PLC is an investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company will not invest more than 15%, in aggregate, of the value of its gross assets in other closed ended investment companies (including investment trusts) listed on the London Stock Exchange. The Company will not invest more than 15% of the value of its gross assets in any one individual stock at the time of acquisition. The Company will not invest more than 10% of the value of its gross assets in direct unquoted investments at the time of acquisition. OrbiMed Capital LLC is its portfolio manager. Frostrow Capital LLP is its alternative investment fund manager.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+44-20-74264000
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£-76,260,000.00
Book ValueGBX 743.10 per share

Profitability

Miscellaneous

Market Cap£544.49 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 1,388.75
-5.25 (-0.38 %)
(As of 10/23/2020 03:48 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIOG News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











The Biotech Growth Trust PLC (BIOG.L) (LON:BIOG) Frequently Asked Questions

How has The Biotech Growth Trust PLC (BIOG.L)'s stock been impacted by Coronavirus?

The Biotech Growth Trust PLC (BIOG.L)'s stock was trading at GBX 846 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIOG shares have increased by 64.2% and is now trading at GBX 1,388.75.
View which stocks have been most impacted by COVID-19
.

What other stocks do shareholders of The Biotech Growth Trust PLC (BIOG.L) own?

What is The Biotech Growth Trust PLC (BIOG.L)'s stock symbol?

The Biotech Growth Trust PLC (BIOG.L) trades on the London Stock Exchange (LON) under the ticker symbol "BIOG."

How do I buy shares of The Biotech Growth Trust PLC (BIOG.L)?

Shares of BIOG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is The Biotech Growth Trust PLC (BIOG.L)'s stock price today?

One share of BIOG stock can currently be purchased for approximately GBX 1,388.75.

How big of a company is The Biotech Growth Trust PLC (BIOG.L)?

The Biotech Growth Trust PLC (BIOG.L) has a market capitalization of £544.49 million and generates £-76,260,000.00 in revenue each year.

What is The Biotech Growth Trust PLC (BIOG.L)'s official website?

The official website for The Biotech Growth Trust PLC (BIOG.L) is www.biotechgt.com.

How can I contact The Biotech Growth Trust PLC (BIOG.L)?

The Biotech Growth Trust PLC (BIOG.L)'s mailing address is 25 Southampton Buildings, LONDON, WC2A 1AL, United Kingdom. The company can be reached via phone at +44-20-74264000.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.